A-317491 structure
|
Common Name | A-317491 | ||
|---|---|---|---|---|
| CAS Number | 475205-49-3 | Molecular Weight | 565.56900 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C33H27NO8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of A-317491A-317491 is a non-nucleotide P2X3 and P2X2/3 receptor antagonist, which inhibits calcium flux mediated by the receptors. IC50 value: Target: P2X2/3It is known that P2X3 and P2X2/3 receptors stimulate the pronociceptive effects of ATP upon activation. Studies indicate that the P2X3 receptor is implicated in both neuropathic and inflammatory pain. P2X3 receptor is a promising target for therapeutic intervention in cancer patients for pain management. |
| Name | 5-[(3-phenoxyphenyl)methyl-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]benzene-1,2,4-tricarboxylic acid |
|---|---|
| Synonym | More Synonyms |
| Description | A-317491 is a non-nucleotide P2X3 and P2X2/3 receptor antagonist, which inhibits calcium flux mediated by the receptors. IC50 value: Target: P2X2/3It is known that P2X3 and P2X2/3 receptors stimulate the pronociceptive effects of ATP upon activation. Studies indicate that the P2X3 receptor is implicated in both neuropathic and inflammatory pain. P2X3 receptor is a promising target for therapeutic intervention in cancer patients for pain management. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C33H27NO8 |
|---|---|
| Molecular Weight | 565.56900 |
| Exact Mass | 565.17400 |
| PSA | 141.44000 |
| LogP | 6.29350 |
| InChIKey | VQGBOYBIENNKMI-LJAQVGFWSA-N |
| SMILES | O=C(O)c1cc(C(=O)O)c(C(=O)N(Cc2cccc(Oc3ccccc3)c2)C2CCCc3ccccc32)cc1C(=O)O |
| Storage condition | -20°C |
| cs-1250 |
| A-317491 |